Low
₹5,108.40
High
₹5,239.60
| Previous Close | ₹5,138.70 |
|---|---|
| Day's Range | ₹5,108.40 - ₹5,239.60 |
| Open | ₹5,205.90 |
| 52 Week Range | ₹4,707.00 - ₹6,739.00 |
| Volume | 12,542 |
| Market Cap | ₹0.01 |
| Trade Value ( ₹ in Lacs) | 644.93 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 2.43 |
| Price/Earning (TTM) | 29.07 |
| TTM EPS (₹) | 176.81 |
| P/E Ratio | 36.42 |
| Book Value(₹) | 12.24 |
| PAT Margin (%) | 22.78 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 58.05 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 3097.7 | 12296.2 |
| Expenses | N/A | 0.0 |
| PBT | 1216.9 | 3142.0 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 909.0 | 2294.7 |
| Founded | 1967 |
|---|---|
| Managing Director | Milind Thatte |
| NSE Symbol | PGHL |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 3,88,680.27 | 1,618.50 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,68,816.78 | 6,342.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,39,297.37 | 4,109.25 | 3,101.60 - 3,101.60 |
| Apollo Hospitals Enterprise Ltd. | 1,11,082.99 | 7,725.00 | 6,677.50 - 6,677.50 |
| Dr. Reddy's Laboratories Ltd. | 1,09,828.34 | 1,312.40 | 1,129.40 - 1,129.40 |
| Lupin Ltd. | 1,04,972.90 | 2,285.05 | 1,836.80 - 1,836.80 |
| Cipla Ltd. | 1,04,587.66 | 1,295.00 | 1,165.70 - 1,165.70 |
| Max Healthcare Institute Ltd. | 97,255.99 | 1,000.05 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 93,581.99 | 2,267.15 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 93,292.98 | 930.00 | 835.50 - 835.50 |
No Records Found
Posted on Apr 25th
Minda Corporation informs about credit rating
Posted on Apr 24th
Amba Auto Sales and Services coming with IPO to raise up to Rs 65.12 crore
Posted on Apr 24th
Bihar CM Samrat Choudhary govt wins trust vote in assembly
Posted on Apr 24th
Currency futures for May expiry trade weaker with 36.44% increase in OI
No Records Found
The current share price of Procter & Gamble Health Ltd. is ₹5,138.70 as of 2026-04-24.
The market capitalisation of Procter & Gamble Health Ltd. is ₹8,532.91 as of 2026-04-24.
The 1-year return of Procter & Gamble Health Ltd. is 0.00% as of 2026-04-24.
The P/E ratio of Procter & Gamble Health Ltd. is 36.42 as of 2026-04-25.
The 52-week high and low of Procter & Gamble Health Ltd. are ₹6,739.00 and ₹4,707.00, respectively, as of 2026-04-24.
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.